Outcomes of Vascular Interventions in Takayasu Arteritis and the Role of Biologic Therapy: A Multicenter Retrospective Study.
Аннотация
OBJECTIVES
Takayasu arteritis (TAK) may lead to arterial stenosis/occlusion and aneurysms, occasionally requiring vascular interventions. We evaluated outcomes, restenosis, and complications after vascular interventions in TAK and explored factors associated with restenosis.
METHODS
We retrospectively included TAK patients who underwent extracardiac endovascular or surgical vascular interventions before or after TAK diagnosis across eight tertiary centers (1995-2024). Indications, disease activity status at the time of intervention, procedural characteristics, early/late outcomes, major complications, and restenosis were recorded. Restenosis was defined as > 70% stenosis on follow-up imaging performed ≥ 3 months after the procedure. Restenosis analyses were restricted to steno-occlusive lesions.
RESULTS
We included 119 patients with 201 treated lesions (185 steno-occlusive lesions; 16 aneurysms/dissections). Of all procedures, 61.2% (n = 123) were performed after TAK diagnosis under immunosuppressive therapy. Follow-up imaging was available for 170/185 steno-occlusive procedures, and restenosis status was evaluable in 168 procedures; restenosis occurred in 82/168 (48.8%) with a median time to restenosis of 19.5 months. In exploratory Kaplan-Meier analysis, 1-, 3-, and 5-year restenosis-free patency rates were 76.8%, 63.6%, and 56.5%, respectively. In analyses restricted to post-diagnosis steno-occlusive procedures, crude restenosis was significantly less frequent under biologic therapy than without biologic therapy (30.8% vs. 53.1%; Fisher's exact p = 0.040); however, biologic therapy was not associated with time to restenosis in Cox regression (HR 1.01, 95% CI 0.51-1.99; p = 0.97) or patient-clustered Cox analysis (HR 1.01, 95% CI 0.47-2.18; p = 0.98). Major complication rates were 3.9% for endovascular procedures and 12.5% for surgical procedures. Overall mortality was 11.8%, with two deaths attributed to procedure-related complications.
CONCLUSIONS
Vascular interventions in selected patients with Takayasu arteritis were associated with acceptable major complication rates. Among post-diagnosis steno-occlusive procedures, biologic therapy was associated with lower restenosis rates in crude analyses; however, this association was not sustained after accounting for restenosis timing. Therefore, the potential role of biologic therapy in improving post-interventional vascular outcomes should be interpreted cautiously and requires confirmation in prospective studies with standardized imaging surveillance.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.